Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' (Deficit) Equity

v3.20.1
Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Common Stock Subscription [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Retained Earnings [Member]
Private Placement [Member]
AOCI Attributable to Parent [Member]
Private Placement [Member]
Noncontrolling Interest [Member]
Private Placement [Member]
Common Stock [Member]
Common Stock Subscription [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2017               8,110,332          
Balance at Dec. 31, 2017               $ 162,207 $ 331,128,787 $ (319,908,968) $ (2,396) $ 668,700 $ 12,048,330
Impact of adoption of ASC Topic 606 at Dec. 31, 2017               (700,000) (700,000)
Issued stock in payment of employee bonuses (in shares)               55,938          
Issued stock in payment of employee bonuses               $ 1,118 315,784 316,902
Issued restricted stock (in shares)               10,000          
Issued restricted stock               $ 200 200
Cancelled forfeited restricted stock (in shares)               (2,500)          
Cancelled forfeited restricted stock               $ (50)  
Cancelled forfeited restricted stock                   50        
Issued stock to 401(k) plan (in shares)               4,734         4,734
Issued stock to 401(k) plan               $ 95 35,885 $ 35,980
Stock Issued (in shares) 916,031                        
Stock Issued $ 18,321 $ 2,981,679 $ 3,000,000              
Issued stock pursuant to termination agreement (in shares)               925,000          
Issued stock pursuant to termination agreement               $ 18,500 3,496,500 3,515,000
Stock compensation expense               306,698 306,698
Net loss               (16,113,937) (379) (16,114,316)
Unrealized gain on available-for-sale securities               1,666 1,666
Total comprehensive income (loss)               (16,112,650)
Balance (in shares) at Dec. 31, 2018               10,019,535          
Balance at Dec. 31, 2018               $ 200,391 338,265,383 (336,722,905) (730) 668,321 2,410,460
Issued restricted stock (in shares)               15,000          
Issued restricted stock               $ 300 $ 300
Issued stock to 401(k) plan (in shares)               8,128         8,128
Issued stock to 401(k) plan               $ 8 19,580 $ 19,588
Stock Issued (in shares) 1,173,411           8,000,000          
Stock Issued $ 1,513 $ 1,088,487 $ 1,090,000 $ 8,000 5,158,441 5,166,441
Stock compensation expense               232,058 232,058
Net loss               (10,948,197) (17) (10,948,214)
Unrealized gain on available-for-sale securities               730 730
Total comprehensive income (loss)               (10,947,484)
Adjustments related to reverse stock split (in shares)               (1,114)          
Adjustments related to reverse stock split               (3,385) (3,385)
Value of warrants issued in connection with public offering               261,288 261,288
Issued stock in payment of services (in shares)               20,000          
Issued stock in payment of services               $ 20 14,780 14,800
Stock subscribed in connection with private placement               $ 902 811,044 811,946
Stock subscribed in connection with private placement (in shares)                 902,162          
Change in estimated fair value of MT warrants               63,000 63,000
Balance (in shares) at Dec. 31, 2019               19,234,960 902,162          
Balance at Dec. 31, 2019               $ 210,232 $ 902 $ 345,847,676 $ (347,671,102) $ 731,303 $ (880,989)